AN new audit of EU
anticoagulant use in European
hospitals has found that more than
half of all European patients
admitted to hospitals who are given
anticoagulants during their stay are
given Sanofi-Aventis’s Clexane
(called Lovenox in France and the
US).
The report, compiled by
Arlington Medical Resources, also
found that patients admitted for
surgical venous thromboembolism
(VTE) primary prophylaxis
accounted for 48% of all inpatient
anticoagulant users.The above article was sent to subscribers in Pharmacy Daily's issue from 30 Sep 10 To see the full newsletter, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 30 Sep 10
THE role and significance of community pharmacy in regional areas was a key focus of discussion for the Nationals leader David Littleproud during last week’s visit to Orana Mall Pharmacy as part of a regional tour.
FREE Pharmacy Daily subscription - never miss another story!
to top
Subscribe to Pharmacy Daily
Pharmacy Daily subscription confirmation
Thank you for signing up! Check your email inbox – you should shortly receive a message with a link which must be clicked to confirm your subscription.
Once you’ve done that you will begin receiving Pharmacy Daily as soon as the next issue is published.